These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 18425006)

  • 1. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
    Stummer W; Reulen HJ; Meinel T; Pichlmeier U; Schumacher W; Tonn JC; Rohde V; Oppel F; Turowski B; Woiciechowsky C; Franz K; Pietsch T;
    Neurosurgery; 2008 Mar; 62(3):564-76; discussion 564-76. PubMed ID: 18425006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.
    Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ
    J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and functional status after resection of recurrent glioblastoma multiforme.
    Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
    Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
    Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
    Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple resections for patients with glioblastoma: prolonging survival.
    Chaichana KL; Zadnik P; Weingart JD; Olivi A; Gallia GL; Blakeley J; Lim M; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2013 Apr; 118(4):812-20. PubMed ID: 23082884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
    Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
    Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
    Lacroix M; Abi-Said D; Fourney DR; Gokaslan ZL; Shi W; DeMonte F; Lang FF; McCutcheon IE; Hassenbusch SJ; Holland E; Hess K; Michael C; Miller D; Sawaya R
    J Neurosurg; 2001 Aug; 95(2):190-8. PubMed ID: 11780887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
    Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of glioblastoma multiforme: with special reference to recurrence.
    Durmaz R; Erken S; Arslantaş A; Atasoy MA; Bal C; Tel E
    Clin Neurol Neurosurg; 1997 May; 99(2):117-23. PubMed ID: 9213056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
    Pichlmeier U; Bink A; Schackert G; Stummer W;
    Neuro Oncol; 2008 Dec; 10(6):1025-34. PubMed ID: 18667747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
    Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
    Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme.
    Senft C; Franz K; Blasel S; Oszvald A; Rathert J; Seifert V; Gasser T
    Technol Cancer Res Treat; 2010 Aug; 9(4):339-46. PubMed ID: 20626200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
    Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
    J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.